The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma

Background Plasma-free metanephrines (PFM) or urinary fractionated metanephrines (UFM) are the preferred biochemical tests for the diagnosis of phaeochromocytoma and paraganglioma (PPGL). Borderline increased results should be followed up to either exclude or confirm diagnosis. Methods We extracted...

Full description

Bibliographic Details
Main Authors: Samsudin, Intan Nureslyna, Page, Michael M., Hoad, Kirsten, Chubb, Paul, Gillett, Melissa, Glendenning, Paul, Vasikaran, Samuel
Format: Article
Language:English
Published: Sage Publications 2018
Online Access:http://psasir.upm.edu.my/id/eprint/74117/
http://psasir.upm.edu.my/id/eprint/74117/1/The%20challenge%20of%20improving%20the%20diagnostic%20yield%20from%20metanephrine%20testing%20in%20suspected%20phaeochromocytoma%20and%20paraganglioma.pdf
_version_ 1848857436809592832
author Samsudin, Intan Nureslyna
Page, Michael M.
Hoad, Kirsten
Chubb, Paul
Gillett, Melissa
Glendenning, Paul
Vasikaran, Samuel
author_facet Samsudin, Intan Nureslyna
Page, Michael M.
Hoad, Kirsten
Chubb, Paul
Gillett, Melissa
Glendenning, Paul
Vasikaran, Samuel
author_sort Samsudin, Intan Nureslyna
building UPM Institutional Repository
collection Online Access
description Background Plasma-free metanephrines (PFM) or urinary fractionated metanephrines (UFM) are the preferred biochemical tests for the diagnosis of phaeochromocytoma and paraganglioma (PPGL). Borderline increased results should be followed up to either exclude or confirm diagnosis. Methods We extracted all PFM and UFM results reported by our laboratory over a six-month period from the laboratory information system. We categorized patients with borderline increased results according to whether follow-up testing had been performed as suggested in the initial laboratory report. Questionnaires were then sent to all requesting doctors and medical notes reviewed where available. Results Two hundred and four patients with borderline increased PFM or UFM were identified. Sixty-five (38.5%) of 169 patients with borderline increased PFM had a repeat test out of which 36 were normal and 29 did not normalize. Of 35 patients with borderline increased UFM, 17 (48.6%) had subsequent PFM measurement, out of which 15 were normal. Questionnaires were returned to 106 (52%) patients. Of these, the most frequent indication for testing was hypertension ( n = 50); 15 patients had an incidental adrenal mass and two of these patients were diagnosed with a phaeochromocytoma. Conclusion Only 38% of patients with borderline increased PFM had a repeat PFM measurement. This was not significantly higher when compared with the 28% in a previous audit that we reported in 2010 ( P = 0.10). Forty-nine per cent of patients with a borderline increased UFM had a repeat UFM or PFM measurement. There remains a substantial possibility of missed detection of PPGL.
first_indexed 2025-11-15T11:57:32Z
format Article
id upm-74117
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T11:57:32Z
publishDate 2018
publisher Sage Publications
recordtype eprints
repository_type Digital Repository
spelling upm-741172020-04-26T19:05:17Z http://psasir.upm.edu.my/id/eprint/74117/ The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma Samsudin, Intan Nureslyna Page, Michael M. Hoad, Kirsten Chubb, Paul Gillett, Melissa Glendenning, Paul Vasikaran, Samuel Background Plasma-free metanephrines (PFM) or urinary fractionated metanephrines (UFM) are the preferred biochemical tests for the diagnosis of phaeochromocytoma and paraganglioma (PPGL). Borderline increased results should be followed up to either exclude or confirm diagnosis. Methods We extracted all PFM and UFM results reported by our laboratory over a six-month period from the laboratory information system. We categorized patients with borderline increased results according to whether follow-up testing had been performed as suggested in the initial laboratory report. Questionnaires were then sent to all requesting doctors and medical notes reviewed where available. Results Two hundred and four patients with borderline increased PFM or UFM were identified. Sixty-five (38.5%) of 169 patients with borderline increased PFM had a repeat test out of which 36 were normal and 29 did not normalize. Of 35 patients with borderline increased UFM, 17 (48.6%) had subsequent PFM measurement, out of which 15 were normal. Questionnaires were returned to 106 (52%) patients. Of these, the most frequent indication for testing was hypertension ( n = 50); 15 patients had an incidental adrenal mass and two of these patients were diagnosed with a phaeochromocytoma. Conclusion Only 38% of patients with borderline increased PFM had a repeat PFM measurement. This was not significantly higher when compared with the 28% in a previous audit that we reported in 2010 ( P = 0.10). Forty-nine per cent of patients with a borderline increased UFM had a repeat UFM or PFM measurement. There remains a substantial possibility of missed detection of PPGL. Sage Publications 2018 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/74117/1/The%20challenge%20of%20improving%20the%20diagnostic%20yield%20from%20metanephrine%20testing%20in%20suspected%20phaeochromocytoma%20and%20paraganglioma.pdf Samsudin, Intan Nureslyna and Page, Michael M. and Hoad, Kirsten and Chubb, Paul and Gillett, Melissa and Glendenning, Paul and Vasikaran, Samuel (2018) The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma. Annals of Clinical Biochemistry, 55 (6). 679 - 684. ISSN 0004-5632; ESSN: 1758-1001 10.1177/0004563218774590
spellingShingle Samsudin, Intan Nureslyna
Page, Michael M.
Hoad, Kirsten
Chubb, Paul
Gillett, Melissa
Glendenning, Paul
Vasikaran, Samuel
The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title_full The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title_fullStr The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title_full_unstemmed The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title_short The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
title_sort challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
url http://psasir.upm.edu.my/id/eprint/74117/
http://psasir.upm.edu.my/id/eprint/74117/
http://psasir.upm.edu.my/id/eprint/74117/1/The%20challenge%20of%20improving%20the%20diagnostic%20yield%20from%20metanephrine%20testing%20in%20suspected%20phaeochromocytoma%20and%20paraganglioma.pdf